Previous Article | Next Article 
Molecular and Cellular Biology, March 1999, p. 1864-1870, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Telomerase Activity Is Sufficient To Allow
Transformed Cells To Escape from Crisis
Tanya L.
Halvorsen,
Gil
Leibowitz, and
Fred
Levine*
Center for Molecular Genetics, University of
California at San Diego, La Jolla, California 92093-0634
Received 20 July 1998/Returned for modification 28 August
1998/Accepted 23 November 1998
 |
ABSTRACT |
The introduction of simian virus 40 large T antigen (SVLT) into
human primary cells enables them to proliferate beyond
their normal replicative life span. In most cases, this temporary
escape from senescence eventually ends in a second
proliferative block known as "crisis," during which the cells cease
growing or die. Rare immortalization events in which cells escape
crisis are frequently correlated with the presence of
telomerase activity. We tested the hypothesis that
telomerase activation is the critical step in the
immortalization process by studying the effects of
telomerase activity in two mortal
SVLT-Rasval12-transformed human pancreatic cell lines,
TRM-6 and
lox5. The telomerase catalytic subunit, hTRT,
was introduced into late-passage cells via retroviral gene transfer.
Telomerase activity was successfully induced in infected cells, as
demonstrated by a telomerase repeat amplification protocol
assay. In each of nine independent infections, telomerase-positive cells formed rapidly dividing cell
lines while control cells entered crisis. Telomere lengths initially
increased, but telomeres were then maintained at their new lengths for
at least 20 population doublings. These results demonstrate that telomerase activity is sufficient to enable transformed
cells to escape crisis and that telomere elongation in these cells
occurs in a tightly regulated manner.
 |
INTRODUCTION |
Primary human and other mammalian
cells, when cultured in vitro, generally exhibit a strictly limited
proliferative life span, after which they permanently exit the cell
cycle but remain viable for long periods in a state termed senescence
(12, 53). The predominant theory of senescence is that
growth arrest is a response to telomere shortening, which occurs as a
result of incomplete replication of the extreme 3' ends of linear
chromosomes (29, 51). Telomerase, a multisubunit
riboprotein, repairs and maintains telomeric ends in mammalian
germ cells, in simple organisms such as yeast and tetrahymena
(4), and in most tumor-derived cell lines (25,
40). The vast majority of normal, cycling somatic cells have no
detectable telomerase activity (25). It is
hypothesized that senescence occurs when the telomere lengths of one or
more chromosomes reach a critical point at which cells are
signaled to exit the cell cycle. This model was strengthened by the
demonstration that the introduction of telomerase activity
into normal, cycling (presenescent) primary cells prolongs the
proliferative life span, perhaps indefinitely (6, 45).
The normal limitation on life span can be bypassed by a variety of
transforming mechanisms that disable key cell cycle regulators (7,
20, 53-55). Transformation by oncogenes such as simian virus 40 large T antigen (SVLT), human papilloma virus E6 and E7, and adenovirus
E1A and E1B triggers entry into the cell cycle and is sufficient to
delay senescence but fails to induce immortality in human cells
(2, 18, 37, 42). Unchecked proliferation ultimately gives
way to slowed growth, altered cell morphology, and high rates of cell
death (21). This end point is most commonly referred to as
"crisis," although other terms, such as mortality checkpoint 2 or
M2, have been used. Crisis and senescence share the property of growth
arrest following a defined number of cell divisions. However, the
well-controlled exit from the cell cycle, the preservation of
chromosomal integrity, and the gradual loss of viability observed
during senescence contrast with the proliferative slowing, chromosomal
instability, and ongoing cell death that characterize cells in crisis.
It is not known whether crisis and senescence share the same underlying etiology.
Because crisis is characterized by severe chromosomal structural
instability (33, 43) and because it has been demonstrated that transformation does not halt telomere shortening during
replication (15, 16), it has been speculated that crisis
occurs when telomere erosion has progressed beyond a second critical
point such that chromosomes become unstable. The best evidence in favor
of a relationship between telomere shortening and crisis is the high
degree of correlation between immortalization and telomere
stabilization. Depending on the cell type, 1 in 105 to 1 in
107 cells will escape crisis and go on to form immortal
lines (24, 41). The rare clones that do emerge from crisis
invariably exhibit some form of telomere stabilization, usually by
telomerase (25) but sometimes by alternate
mechanisms (9), implying that telomere stabilization is
crucial to continued growth. Conversely, immortal HeLa cells can be
forced into crisis when the telomerase holoenzyme is
disabled by the expression of antisense hTR (the RNA component of the
enzyme) (19).
Specific chromosomal changes observed in crisis are consistent with
telomere loss. Mean telomeric TTAGGG lengths reported for cells in
crisis are so low (1.5 to 2 kb) (15, 16, 27, 29) as to raise
the possibility that at least some chromosome ends may have been eroded
into subtelomeric regions (1, 17, 31, 51). Intertelomere
associations become common, and dicentric chromosomes increase in
frequency (16, 21, 33, 37, 43). These are predicted
consequences of telomere loss and are similar to chromosomal defects
seen in serially passaged cells from mTR knockout mice (5).
Despite the strong correlation between crisis and telomere loss (or
immortalization and telomere stabilization), a causal relationship
between these events has not been definitively established.
As part of an effort to understand the relationship between pancreatic
endocrine cell growth and differentiation, we have been developing cell
lines from the human fetal and adult pancreas using a retroviral
vector expressing SVLT and H-rasval12 (48,
49). The TRM-6 (49) and
lox5 cell lines were
established from human fetal and adult pancreatic islets, respectively.
Like other cells transformed or cotransformed with SVLT, these cells exhibit an extended life span but eventually enter a crisis phase characterized by increased cell death, altered morphology, and lack of
proliferation. Although many human cell types expressing SVLT have
eventually produced rare clones that escaped crisis and went on to form
immortal lines, attempts to derive immortal clones from TRM-6 or
lox5 cells have been unsuccessful so far. Because
telomerase activation may be the primary means by which cells escape crisis and because introduction of the human
telomerase reverse transcriptase (hTRT) subunit
(34) has been shown to reconstitute telomerase
activity in several human cell types (35, 50), we tested the
hypothesis that hTRT expression could rescue TRM-6 and
lox5 cells
from crisis.
 |
MATERIALS AND METHODS |
Plasmids and viruses.
The hTRT-expressing retroviral vector,
LTRTNLlox (Fig. 1), was created from the
retroviral construct Lluc70AUGNeo (28). The vector was
modified by insertion of a loxP site into the
XbaI site of the 3' long terminal repeat (LTR) (13,
38). The luciferase gene from Lluc70AUGNeo was removed by
HindIII digestion and replaced with a cassette
consisting of a modified Rous sarcoma virus (RSV) LTR promoter
(56) and a HincII-HindIII fragment
containing the herpes simplex virus thymidine kinase (tk)
gene (32). The HincII site is 63 bp upstream of
the ATG start codon, and the HindIII site was inserted
by PCR, 27 bp downstream of the stop codon. The neomycin
phosphotransferase gene is directly 3' of the tk gene and is
expressed by a ribosomal translational scanning mechanism (28). Finally, the hTRT gene (34) was subcloned
into a NotI site inserted downstream of the 5' viral LTR
promoter, which drives its expression. The LTPRRTNLlox vector used in
the creation of the
lox5 cell line (see below) is identical to
LTRTNLlox except that the NotI-flanked
SVLT-Po-RasVal12 cassette from
LOTPRRNLO (47) replaces the hTRT
gene. The green fluorescent protein (GFP)-expressing control construct,
LGFPRNL (57a), was created by the insertion of the GFP µ2
gene (14) into the BamHI site of the retroviral
vector LZRNL (56). 293GP-derived producer cell lines were
created for each construct, and vesicular stomatitis virus G
(VSV-G)-pseudotyped retrovirus was harvested as previously
described (10, 46).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 1.
A schematic diagram showing the hTRT-expressing
retroviral vector LTRTNLlox. The retroviral LTR has internal promoter
activity, which drives the expression of hTRT. A modified RSV promoter
drives the expression of the tk and neo genes.
The herpes simplex virus thymidine kinase (tk) gene induces
gancyclovir sensitivity. The neomycin phosphotransferase gene
(neo) imparts G418 resistance. A loxP site
(crosshatched box) has been inserted into the 3' viral LTR. The
duplication of the loxP site during retroviral insertion
allows the intervening sequences to be eliminated when
cre is expressed (13, 38).
|
|
Cells and cell culture.
TRM-6 cells are derived from 24-week
human fetal pancreatic epithelial cells transformed with SVLT antigen
and Rasval12 (49).
lox5 cells are derived
from adult human pancreatic islet cells (provided by the Diabetes
Research Institute, Miami, Fla.) which were sorted for high flavin
adenine dinucleotide autofluorescence in order to enrich for
-cells
(44). They were transformed by LTPRRTNLlox. Basinger cells
are human primary fibroblast cells (46). All cells were
maintained in Dulbecco's modified Eagle medium supplemented with 10%
fetal bovine serum and 400 ng of G418/ml, except for Basinger cells,
which were maintained without G418 until after infection with LTRTNLlox
or LGFPRNL. Infections were carried out in the presence of 6 µg of
Polybrene/ml.
Growth rate analysis.
Cells were seeded into 35-mm wells at
a density of 10,000 cells/well. Cells were passaged at 80% confluency
(except for controls lacking telomerase activity, which
never reached that density) and were counted on days 7, 13, 17, and 22.
TRAP assay.
Cell extracts were prepared, and the
telomerase repeat amplification protocol (TRAP) assays were
performed with the TRAPEZE enzyme-linked immunosorbent assay (ELISA)
telomerase detection kit (Oncor, Gaithersburg, Md.)
as directed by the manufacturer. Samples were assayed in
duplicate. Heat-treated controls from each sample were included in
order to rule out false-positive signals from PCR artifacts.
Telomere length analysis.
Genomic DNA was isolated by
proteinase K lysis and phenol-choroform extraction. For telomere length
comparisons, 3.0 µg of genomic DNA was digested with RsaI
and HinfI restriction enzymes and separated on a 0.6%
agarose gel. The DNA was transferred to a positively charged nylon
membrane by Southern blotting and was probed with
32P-labeled 5'-(CCCTAA)5. Radioactive signals
were either detected on a phosphor screen and scanned with a Storm
Scanner (Molecular Dynamics, Sunnyvale, Calif.) or detected on X-ray
film and scanned with a Hewlett-Packard ScanJet 6100C. Signal densities
were analyzed with Scion Image software (Scion Corp., Frederick, Md.).
Mean telomere restriction fragment (TRF) lengths were calculated as previously described (22).
In the comparison of telomere lengths as a function of cell division,
population doublings (PD) were determined as follows.
Cells were
arbitrarily designated PD 0 at the time of infection.
The number of
cell divisions that occurred in emerging colonies
prior to the first
passage was estimated at 10 based on the number
of cells in a typical
colony. Subsequent PD were calculated as
a function of passage number
and splitting
ratio.
 |
RESULTS |
Development of an hTRT-expressing retroviral vector.
Retroviral gene transfer vectors provide a simple and
efficient means of integrating exogenous DNA into the host chromosomes of dividing cells. We designed an hTRT-expressing retroviral vector to
test the effects of telomerase activity in populations
of SVLT-Rasval12-transformed cells. The hTRT gene
(34) was subcloned into a retroviral vector to create
pLTRTNLlox. Expression of hTRT is driven by the viral
5' LTR (Fig. 1). A GFP-expressing retroviral vector, pLGFPRNL,
was used as a control. Retroviruses were pseudotyped with the VSV-G
envelope protein in order to maximize their ability to
infect mammalian cells (10, 46).
To test the ability of our vector to express functional hTRT
protein, Basinger human primary fibroblasts (
46) were
infected
with LTRTNLlox or LGFPRNL and selected in G418.
A TRAP assay confirmed
that only LTRTNLlox-infected cells
acquired telomerase activity
(data not shown). In agreement
with the results of Bodnar et al.
(
6), Basinger fibroblast
cultures expressing hTRT from LTRTNLlox
continued to proliferate well
beyond the point at which control
cells senesced (data not
shown).
Expression of hTRT in human pancreatic cell lines confers
telomerase activity.
Previous studies found that the
hTR RNA and hTLP1 protein subunits of telomerase were
ubiquitously expressed (19, 35) and that hTRT was the only
missing factor required for telomerase activity (35,
50). However, the number of cell lines tested was small,
and the effects of SVLT and H-rasval12 expression on the
expression or activity of those telomerase subunits
are unknown. Therefore, it was important to determine whether hTRT
expression in human pancreatic cell lines is sufficient to reconstitute
telomerase activity.
Late-passage TRM-6 cells and

lox5 cells, judged by their slowed
growth and the appearance of altered morphology to be approaching
crisis, were seeded into 35-mm wells and infected with either
LGFPRNL
or LTRTNLlox retrovirus at four different multiplicities
of infection
(MOIs) ranging from 1 to 10. Although selection was
precluded by the
fact that TRM-6 and

lox5 cells are already G418
resistant, previous
studies using GFP as a marker have demonstrated
infection efficiencies
as high as 40% in TRM-6 cells with LGFPRNL
at an MOI of 10 (
24a). ELISA-based TRAP assays performed on extracts
from
LGFPRNL- and LTRTNLlox-infected TRM-6 cells confirmed that
the
LTRTNLlox-infected cells were strongly positive for
telomerase
activity for at least 7 weeks after infection,
whereas no such
activity was detectable in control cells (Fig.
2).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
A TRAP ELISA was performed on extracts from control
(TRM-6GFP) and LTRTNLlox-infected (TRM-6T) cells 48 days postinfection.
TRM-6T1 and TRM-6T2 are derived from independent infections of TRM-6
with LTRTNLlox. Samples were tested in duplicate. Absorbance was
measured at 450 and 690 nm. The A690 was
subtracted to eliminate background absorbance from the plate. The
absorbance of controls in which telomerase was inactivated
by heat treatment was then subtracted in order to control for PCR
artifacts. The final values are shown. The dashed line delineates the
threshold above which the assay is considered positive.
|
|
TRM-6 and
lox5 cells are consistently rescued from crisis by the
introduction of hTRT.
Cells infected with LGFPRNL or LTRTNLlox
were passaged continuously. Within 3 weeks (2 to 3 PD), 3 of 3 uninfected cultures and 8 of 8 LGFPRNL-infected control cultures
had stopped proliferating (failed to exceed 50% confluency) and
comprised mainly large, flattened cells with low
nucleus/cytoplasm ratios and highly variable morphology (Fig.
3A). A low level of ongoing cell death
was also observed, consistent with crisis. During the same 3-week
period, 5 of 5 independent LTRTNLlox-infected TRM-6 cultures and 4 of 4 independent LTRTNLlox-infected
lox5 cultures gave rise to numerous small colonies of rapidly dividing cells (Fig. 3B), generating the
polyclonal TRM-6T lines 1 to 5 and
lox5T lines 1 to 4, respectively. These cells were easily distinguishable by their
morphology from surrounding cells that underwent growth arrest, and
they were numerous enough to be readily observed at low-power
magnification in virtually every field. The presence of colonies on 9 of 9 LTRTNLlox-infected plates and the absence of proliferation on
control plates indicate that proliferation and escape from crisis
occurred as a direct result of infection by LTRTNLlox. The large number
of colonies on LTRTNLlox-infected plates suggests that escape from
crisis occurred in a high percentage of infected cells.
lox5T and
TRM-6T cells have continued to grow (Fig.
4 and data not shown) and have been
maintained in culture for more than 35 and 45 PD, respectively.

View larger version (97K):
[in this window]
[in a new window]
|
FIG. 3.
Differences in growth and morphology of control (TRM-6)
and hTRT-expressing (TRM-6T) cells are shown. (A) TRM-6GFP cells have
failed to reach confluency after more than 2 weeks in culture. The
arrow points to an enlarged cell with a flattened appearance and a
decreased nucleus/cytoplasm ratio, typical of those seen in crisis. (B)
TRM-6T cells were seeded at the same time as control cells and had been
passaged twice at the time that the picture was taken. Magnification,
×10.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
A growth curve charts the differences in proliferative
capacity between control ( lox5 and lox5GFP) and
telomerase-positive cells. Blox5T1, lox5T2, and
lox5T3 are derived from independent infections of lox5 with
LTRTNLlox.
|
|
Induction of telomerase activity lengthens the
telomeres of transformed cell lines.
Bodnar et al. showed that
hTRT gene transfer resulted in telomere elongation in primary cells
(6). In contrast, immortalized, transformed cell lines that
have acquired telomerase activity by an as yet
uncharacterized genetic or epigenetic event generally retain short, but
stable, telomeres (15, 16). The effect of constitutive
expression of a transduced hTRT gene on telomere length in transformed
cells has not been examined. Therefore, the mean TRF lengths of
the hTRT-expressing TRM-6T and
lox5T cells were measured
and compared to those of near-crisis and crisis stage control cells.
TRFs were generated by cutting genomic DNA with restriction
enzymes (RsaI and HinfI) which cut sites in
subtelomeric regions but do not cleave telomeric repeats. Genomic
DNA for telomere length analysis was harvested as soon as
control cells had clearly entered crisis, as determined by
growth arrest, and at various time points thereafter up to PD 34 (for
lox5T) and PD 40 (for TRM-6T), calculated as described in Materials
and Methods. DNA was also harvested from uninfected
lox5 cells prior
to the onset of crisis.
The hTRT-expressing cells have an increase in the average telomere
length compared to either crisis phase or precrisis control
cells. The

lox5T cells exhibited the most impressive lengthening
(Fig.
5A) and the most consistent length
regulation between independent
lines (Fig.
5A) and over many cell
divisions (Fig.
5C, lanes 1
to 5). Marked lengthening of the telomeres
was evident at the
earliest time point (Fig.
5A, lanes 6 and 7), and
they reached
a maximum length by PD 15 (Fig.
5A, lanes 8 to 11), after
which
they appeared to remain stable for at least 20 PD (Fig.
5C). The
mean of the TRF lengths of the four independent

lox5T cultures
was
approximately 15 kb, and they had a narrow distribution. A
marked
increase in signal intensity at the target length (15 kb)
became
evident at later PD (Fig.
5C, lanes 4 and 5). This was
not due to
uneven loading of the DNA, as confirmed by ethidium
bromide staining
(data not shown). The TRF lengths of TRM-6T cells
demonstrated
less-dramatic lengthening and more variability between
and within
independent lines (Fig.
5B). Mean TRF lengths ranged
from 7 to 10 kb, with broadly distributed signals, although this
distribution
narrowed with increasing PD (Fig.
5C, lanes 6 to
10). Interestingly,
the gradual convergence of TRM-6T TRF lengths
appeared to involve
shortening or loss of some long telomere populations
as well as
elongation of others (Fig.
5C, lanes 6 to 10). The
striking difference
in the size, distribution, and dynamics of
TRF lengths between
TRM-6T and

lox5T lines demonstrates cell
line-specific regulation of
telomere length.

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 5.
Southern blots showing TRF lengths in control and
telomerase-positive cells. (A) lox5 derivatives. Lanes:
1, precrisis lox5 cells; 2, lox5 cells in crisis; 3 to 5, independent lox5GFP controls in crisis; 6 to 7, independent lox5T
lines at PD 10; 8 to 11, independent lox5T lines at PD 14 to 15. (B)
TRM-6 derivatives. Lanes: 1, TRM-6 cells in crisis; 2 to 3, TRM-6GFP
cells in crisis; 4 to 7, independent TRM-6T lines at PD 17 to 18. (C)
Telomere length dynamics. Lanes 1 through 5, lox5T3 cells at PD 10, 15, 22, 28, and 34, respectively. Lanes 6 through 10, TRM-6T2 cells at
PD 10, 17, 25, 34, and 40, respectively.
|
|
 |
DISCUSSION |
The most important conclusion of this study is that telomerase
activity is sufficient to allow transformed cells to escape from
crisis. Although hTRT expression is sufficient to prevent senescence in
normal, cycling cells, its efficacy in enabling transformed cells to
bypass crisis had not been tested previously. Here, we have shown
directly that hTRT gene expression is sufficient to initiate
telomerase activity and to prevent crisis in late-passage pancreatic epithelial cells transformed with SVLT and
Rasval12. Although additional studies will be required to
determine whether these results can be generalized to other cell lines
and other models of transformation, our findings demonstrate that
telomere erosion is a primary factor responsible for the onset of
crisis in transformed cell cultures. Previous studies correlating
escape from crisis with the appearance of telomerase
activity could not rule out the possibility that other events were
occurring and playing a role in this process. The consistency and
rapidity with which the differences between LTRTNLlox-infected and
control cells became evident argues against the need for any additional events.
Another question that our study addresses regards the regulation of
telomere length in hTRT-expressing cells. We found that TRM-6 and
lox5 cells at the point of crisis both demonstrated significant
telomere elongation upon the introduction of hTRT, with subsequent
stabilization. Telomere elongation following the introduction of the
hTRT transgene has been demonstrated in other models. Bodnar et al.
reported that the telomere lengths of stable, hTRT-expressing clones of
primary human fibroblasts and retinal pigment epithelial cells were
longer than those of the starting populations at the time of
transfection (6). Similar results were reported by Vaziri
and Benchimol (45). These experiments, however, were
performed in presenescent primary cell cultures, not in transformed
cells nearing crisis. In contrast, many previous studies of immortal
tumor cell lines have found that they characteristically have stable
telomeres that are significantly shorter than those found in young
primary cells (17, 39). This suggests that in most
spontaneously transformed cells, telomeres are maintained within a
constant range but are not elongated. It was presumed that
stabilization occurred at the moment at which telomerase became active. Likewise, detailed studies of telomere lengths during
spontaneous immortalization of simian virus 40-, adenovirus-, and
Epstein-Barr virus-transformed cells found stabilization of telomeres
without elongation (15, 16), although telomere elongation was seen in a study of human papillomavirus-transformed cell lines (27).
Any of a number of possible mechanisms could account for the telomere
lengthening seen in our system compared to the maintenance of stable,
short telomeres seen in most spontaneously immortalized transformed
cells. There may be differences in the expression level of hTRT, and
consequently in telomerase activity, between spontaneously
immortalized cells and cells genetically modified to express
hTRT. Indeed, detailed studies of HeLa and 293 cells, both of which
have "stable" telomere lengths, demonstrated that telomere
stabilization in these cell lines is actually a dynamic process,
with subpopulations exhibiting varying levels (or an absence)
of telomerase activity at different times
(8). Constitutively expressed transgenic hTRT may be less
susceptible to repression or inactivation. Another possibility is that
telomere length is controlled by other factors that are not reflected
in telomerase activity as measured by the TRAP assay. Such
factors could be specific to a particular cell type and/or could be
influenced by the mechanism by which the cell was transformed.
We consider it unlikely that the apparent telomere lengthening observed
in our experiments represents telomere stabilization in a few rare
cells having unusually long telomeres at the time at which the culture
was infected with LTRTNLlox. This is most clear in the
lox5
experiment, in which the vast majority of the parental cells clearly
had very short TRFs. Since the independent
lox5T lines represent
polyclonal populations, as indicated by the large number of colonies
observed, stabilization without elongation should have generated a
majority of very short TRFs. Instead, all four lines had a narrow
distribution of TRF lengths, with a mean of 15 kb. It is highly
unlikely that any cells in a population on the verge of crisis, as
these were, would have TRFs in the 15-kb range. Previous studies have
consistently shown that crisis occurs when TRF lengths average less
than 4 kb (15, 16, 27, 29). Furthermore, in two
cases we were able to demonstrate mean TRF lengths in samples taken
very early after LTRTNLlox infection that were intermediate between
those of control cells and the length at which the same lines
ultimately stabilized (Fig. 5A, lanes 6 to 7, and 5C, lane 1). Finally,
as discussed further below, independent
lox5T lines had very
similar mean TRF lengths and TRF length distributions. More variability
between individual cell lines might have been expected if atypical
populations were being selected by telomere stabilization.
Once the telomeres are elongated, it is clear that the ultimate length
is tightly regulated in a cell line-specific manner. Multiple
independent (but concurrent) infections of each of the two cell lines
studied here demonstrated that the telomeres in independent lines
originating from the same parent strain were consistently lengthened to
similar extents but that TRM-6T lines maintained much shorter TRF
lengths than
lox5T lines. Elongation occurred early after infection
and remained stable for at least 20 cell divisions.
lox5T cells
demonstrated much more stringently regulated telomere lengths than
TRM-6T cells, with little deviation occurring either with
increasing PD or between independent lines. Interestingly, the
probe signal increased in intensity at later PDs in
lox5T
cells, although the mean TRF length remained essentially unchanged.
While the significance of this is unclear at present, one possible
explanation is that telomere lengthening continues to occur over many
generations, with an increasing proportion of cells in the population
and/or an increasing proportion of chromosomes in each cell having
undergone telomere elongation at each time point. TRM-6T cells
also demonstrated an increasingly focused signal, although TRF
length modification in these lines seemed to involve loss or shortening
of longer telomere subpopulations over time. The increasing homogeneity
of TRF lengths in the cultures could simply reflect selective expansion
of one or a few clones within the population. This does not change the
observation that telomere length is closely regulated. It is not known
what determines the ultimate length at which telomeres will be
maintained in a given cell type, although mean TRF lengths within
species (germ lines) or cell lines are stringently maintained (3,
15, 26, 58). Mean TRF lengths in the
lox5T lines are similar
to those reported in human fetal tissues (11, 57),
although the TRM-6T lines failed to reach this length. The
stabilization of telomere length over time in the hTRT-expressing lines
demonstrates that regulation of telomere length persists despite
constitutive overexpression of hTRT mRNA. This is
consistent with previous evidence suggesting that telomere
lengths are regulated by other means, such as factors that bind
directly to telomeric DNA (23, 30, 36, 52, 59). Alternatively, telomere stabilization may simply reflect an equilibrium between telomerase activity and telomere loss, either of which could be positively or negatively affected by as yet uncharacterized regulatory factors. The fact that telomere length increased in our
cells (and in those of others using an hTRT transgene) could be due to
a partial or temporary overwhelming of inhibitory regulators by
overexpression of hTRT. Future studies will be needed to look more
specifically at the relationship between hTRT expression, telomerase activity, and telomere length
regulatory mechanisms.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Stern Foundation and
the Juvenile Diabetes Foundation International, and by a pilot grant
from the Howard Hughes Medical Institute. T. Halvorsen is a recipient
of a Medical Scientist Training Program Award. F. Levine is a member of
the UCSD Center for Molecular Genetics, UCSD Cancer Center, and
Whittier Institute for Diabetes.
We thank Camillo Recordi for providing adult human islets, L. Yu for
providing reagents, and G. Beattie, A. Hayek, and members of the Levine
laboratory for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
California, San Diego, Center for Molecular Genetics, Rm. 122, La
Jolla, CA 92093-0634. Phone: (619) 534-5979. Fax: (619)
534-1422. E-mail: flevine{at}ucsd.edu.
 |
REFERENCES |
| 1.
|
Allshire, R. C.,
M. Dempster, and N. D. Hastie.
1989.
Human telomeres contain at least three types of G-rich repeat distributed nonrandomly.
Nucleic Acids Res.
17:4611-4627[Abstract/Free Full Text].
|
| 2.
|
Benjamin, T., and P. K. Vogt.
1990.
Cell transformation by viruses, p. 317-368.
In
B. N. Fields, et al. (ed.), Virology, 2nd ed. Raven Press, Ltd., New York, N.Y.
|
| 3.
|
Blackburn, E. H.
1991.
Structure and function of telomeres.
Nature
350:569-573[Medline].
|
| 4.
|
Blackburn, E. H.
1991.
Telomeres.
Trends Biochem. Sci.
16:378-381[Medline].
|
| 5.
|
Blasco, M. A.,
H. W. Lee,
M. P. Hande,
E. Samper,
P. M. Lansdorp,
R. A. DePinho, and C. W. Greider.
1997.
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [see comments].
Cell
91:25-34[Medline].
|
| 6.
|
Bodnar, A. G.,
M. Ouellette,
M. Frolkis,
S. E. Holt,
C. P. Chiu,
G. B. Morin,
C. B. Harley,
J. W. Shay,
S. Lichtsteiner, and W. E. Wright.
1998.
Extension of life-span by introduction of telomerase into normal human cells [see comments].
Science
279:349-352[Abstract/Free Full Text].
|
| 7.
|
Brown, J. P.,
W. Wei, and J. M. Sedivy.
1997.
Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts.
Science
277:831-834[Abstract/Free Full Text].
|
| 8.
|
Bryan, T. M.,
A. Englezou,
M. A. Dunham, and R. R. Reddel.
1998.
Telomere length dynamics in telomerase-positive immortal human cell populations.
Exp. Cell Res.
239:370-378[Medline].
|
| 9.
|
Bryan, T. M.,
A. Englezou,
J. Gupta,
S. Bacchetti, and R. R. Reddel.
1995.
Telomere elongation in immortal human cells without detectable telomerase activity.
EMBO J.
14:4240-4248[Medline].
|
| 10.
|
Burns, J. C.,
T. Friedmann,
W. Driever,
M. Burrascano, and J.-K. Yee.
1993.
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
Proc. Natl. Acad. Sci. USA
90:8033-8037[Abstract/Free Full Text].
|
| 11.
|
Butler, M. G.,
J. Tilburt,
A. DeVries,
B. Muralidhar,
G. Aue,
L. Hedges,
J. Atkinson, and H. Schwartz.
1998.
Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages.
Cancer Genet. Cytogenet.
105:138-144[Medline].
|
| 12.
|
Campisi, J.
1997.
The biology of replicative senescence.
Eur. J. Cancer
33:703-709.
|
| 13.
|
Choulika, A.,
V. Guyot, and J.-F. Nicolas.
1996.
Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site.
J. Virol.
70:1792-1798[Abstract].
|
| 14.
|
Cormack, B. P.,
R. H. Valdivia, and S. Falkow.
1996.
FACS-optimized mutants of the green fluorescent protein (GFP).
Gene
173:33-38[Medline].
|
| 15.
|
Counter, C. M.,
A. A. Avilion,
C. E. LeFeuvre,
N. G. Stewart,
C. W. Greider,
C. B. Harley, and S. Bacchetti.
1992.
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
EMBO J.
11:1921-1929[Medline].
|
| 16.
|
Counter, C. M.,
F. M. Botelho,
P. Wang,
C. B. Harley, and S. Bacchetti.
1994.
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes.
J. Virol.
68:3410-3414[Abstract/Free Full Text].
|
| 17.
|
de Lange, T.,
L. Shiue,
R. M. Myers,
D. R. Cox,
S. L. Naylor,
A. M. Killery, and H. E. Varmus.
1990.
Structure and variability of human chromosome ends.
Mol. Cell. Biol.
10:518-527[Abstract/Free Full Text].
|
| 18.
|
De Silva, R.,
N. J. Whitaker,
E. M. Rogan, and R. R. Reddel.
1994.
HPV-16 E6 and E7 genes, like SV40 early region genes, are insufficient for immortalization of human mesothelial and bronchial epithelial cells.
Exp. Cell Res.
213:418-427[Medline].
|
| 19.
|
Feng, J.,
W. D. Funk,
S. S. Wang,
S. L. Weinrich,
A. A. Avilion,
C. P. Chiu,
R. R. Adams,
E. Chang,
R. C. Allsopp,
J. Yu,
S. Le,
M. D. West,
C. B. Harley,
W. H. Andrews,
C. W. Greider, and B. Villeponteau.
1995.
The RNA component of human telomerase.
Science
269:1236-1241[Abstract/Free Full Text].
|
| 20.
|
Garkavtsev, I.,
C. Hull, and K. Riabowol.
1998.
Molecular aspects of the relationship between cancer and aging: tumor suppressor activity during cellular senescence.
Exp. Gerontol.
33:81-94[Medline].
|
| 21.
|
Girardi, A. J.,
F. C. Jensen, and H. Koprowski.
1965.
SV40-induced transformation of human diploid cells: crisis and recovery.
J. Cell. Comp. Physiol.
65:69-84.
|
| 22.
|
Harley, C. B.,
A. B. Futcher, and C. W. Greider.
1990.
Telomeres shorten during ageing of human fibroblasts.
Nature
345:458-460[Medline].
|
| 23.
|
Holt, S. E.,
W. E. Wright, and J. W. Shay.
1997.
Multiple pathways for the regulation of telomerase activity.
Eur. J. Cancer
33:761-766.
|
| 24.
|
Huschtscha, L. I., and R. Holliday.
1983.
Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts.
J. Cell Sci.
63:77-99[Abstract].
|
| 24a.
| Itkin-Ansari, P. R. Unpublished data.
|
| 25.
|
Kim, N. W.,
M. A. Piatyszek,
K. R. Prowse,
C. B. Harley,
M. D. West,
P. L. Ho,
G. M. Coviello,
W. E. Wright,
S. L. Weinrich, and J. W. Shay.
1994.
Specific association of human telomerase activity with immortal cells and cancer [see comments].
Science
266:2011-2015[Abstract/Free Full Text].
|
| 26.
|
Kipling, D., and H. J. Cooke.
1990.
Hypervariable ultra-long telomeres in mice.
Nature
347:400-402[Medline].
|
| 27.
|
Klingelhutz, A. J.,
S. A. Barber,
P. P. Smith,
K. Dyer, and J. K. McDougall.
1994.
Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells.
Mol. Cell. Biol.
14:961-969[Abstract/Free Full Text].
|
| 28.
|
Levine, F.,
J.-K. Yee, and T. Friedmann.
1991.
Efficient gene expression in mammalian cells from a dicistronic transcriptional unit in an improved retroviral vector.
Gene
108:167-174[Medline].
|
| 29.
|
Levy, M. Z.,
R. C. Allsopp,
A. B. Futcher,
C. W. Greider, and C. B. Harley.
1992.
Telomere end-replication problem and cell aging.
J. Mol. Biol.
225:951-960[Medline].
|
| 30.
|
McEachern, M. J., and E. H. Blackburn.
1995.
Runaway telomere elongation caused by telomerase RNA gene mutations.
Nature
376:403-409[Medline].
|
| 31.
|
McElligott, R., and R. J. Wellinger.
1997.
The terminal DNA structure of mammalian chromosomes.
EMBO J.
16:3705-3714[Medline].
|
| 32.
|
McKnight, S. L.
1980.
The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene.
Nucleic Acids Res.
8:5949-5964[Abstract/Free Full Text].
|
| 33.
|
Moorhead, P. S., and E. Saksela.
1965.
The sequence of chromosome aberrations during SV40 transformation of a human diploid cell strain.
Hereditas
52:271-284[Medline].
|
| 34.
|
Nakamura, T. M.,
G. B. Morin,
K. B. Chapman,
S. L. Weinrich,
W. H. Andrews,
J. Lingner,
C. B. Harley, and T. R. Cech.
1997.
Telomerase catalytic subunit homologs from fission yeast and human [see comments].
Science
277:955-959[Abstract/Free Full Text].
|
| 35.
|
Nakayama, J.,
H. Tahara,
E. Tahara,
M. Saito,
K. Ito,
H. Nakamura,
T. Nakanishi,
T. Ide, and F. Ishikawa.
1998.
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.
Nat. Genet.
18:65-68[Medline].
|
| 36.
|
Runge, K. W., and V. A. Zakian.
1989.
Introduction of extra telomeric DNA sequences into Saccharomyces cerevisiae results in telomere elongation.
Mol. Cell. Biol.
9:1488-1497[Abstract/Free Full Text].
|
| 37.
|
Sack, G. H., Jr.
1981.
Human cell transformation by simian virus 40 a review.
In Vitro
17:1-19[Medline].
|
| 38.
|
Sauer, B., and N. Henderson.
1988.
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.
Proc. Natl. Acad. Sci. USA
85:5166-5170[Abstract/Free Full Text].
|
| 39.
|
Schmitt, H.,
N. Blin,
H. Zankl, and H. Scherthan.
1994.
Telomere length variation in normal and malignant human tissues.
Genes Chromosomes Cancer
11:171-177[Medline].
|
| 40.
|
Shay, J. W., and S. Bacchetti.
1997.
A survey of telomerase activity in human cancer.
Eur. J. Cancer
33:787-791.
|
| 41.
|
Shay, J. W.,
B. A. Van Der Haegen,
Y. Ying, and W. E. Wright.
1993.
The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen.
Exp. Cell Res.
209:45-52[Medline].
|
| 42.
|
Shay, J. W.,
W. E. Wright, and H. Werbin.
1991.
Defining the molecular mechanisms of human cell immortalization.
Biochim. Biophys. Acta
1072:1-7[Medline].
|
| 43.
|
Stewart, N., and S. Bacchetti.
1991.
Expression of SV40 large T antigen, but not small T antigen, is required for the induction of chromosomal aberrations in transformed human cells.
Virology
180:49-57[Medline].
|
| 44.
|
Van de Winkle, M.,
E. Maes, and D. Pipeleers.
1982.
Islet cell analysis and purification by light scatter and autofluorescence.
Biochem. Biophys. Res. Commun.
107:525-532[Medline].
|
| 45.
|
Vaziri, H., and S. Benchimol.
1998.
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.
Curr. Biol.
8:279-282[Medline].
|
| 46.
|
Wang, S.,
G. Beattie,
A. Hayek, and F. Levine.
1996.
Transformation of human primary fibroblasts by pseudotyped retroviral vectors expressing multiple dominant oncogenes from an inducible promoter.
Gene
182:145-150[Medline].
|
| 47.
|
Wang, S.,
G. M. Beattie,
M. I. Mally,
V. Cirulli,
P. Itkin-Ansari,
A. D. Lopez,
A. Hayek, and F. Levine.
1997.
Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas.
Cell Transplant.
6:59-67[Medline].
|
| 48.
|
Wang, S.,
G. M. Beattie,
M. I. Mally,
V. Cirulli,
A. D. Lopez,
A. Hayek, and F. Levine.
1996.
Development and characterization of cell line from human pancreatic beta-cells and beta-cell precursors using retroviral vectors expressing SV40 T-antigen and H-rasval12.
Diabetes
45(Suppl. 2):285A.
|
| 49.
|
Wang, S.,
G. M. Beattie,
M. I. Mally,
A. D. Lopez,
A. Hayek, and F. Levine.
1997.
Analysis of a human fetal pancreatic islet cell line.
Transplant. Proc.
29:2219[Medline].
|
| 50.
|
Weinrich, S. L.,
R. Pruzan,
L. Ma,
M. Ouellette,
V. M. Tesmer,
S. E. Holt,
A. G. Bodnar,
S. Lichtsteiner,
N. W. Kim,
J. B. Trager,
R. D. Taylor,
R. Carlos,
W. H. Andrews,
W. E. Wright,
J. W. Shay,
C. B. Harley, and G. B. Morin.
1997.
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.
Nat. Genet.
17:498-502[Medline].
|
| 51.
|
Wellinger, R. J., and D. Sen.
1997.
The DNA structures at the ends of eukaryotic chromosomes.
Eur. J. Cancer
33:735-749.
|
| 52.
|
Wright, W. E.,
D. Bra i kyt ,
M. A. Piatyszek, and J. W. Shay.
1996.
Experimental elongation of telomeres extends the lifespan of immortal × normal cell hybrids.
EMBO J.
15:1734-1741[Medline].
|
| 53.
|
Wynford-Thomas, D.
1997.
Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology.
Eur. J. Cancer
33:716-726.
|
| 54.
|
Wynford-Thomas, D.
1996.
Telomeres, p53 and cellular senescence.
Oncol. Res.
8:387-398[Medline].
|
| 55.
|
Wynford-Thomas, D.,
C. J. Jones, and F. S. Wyllie.
1996.
The tumour suppressor gene p53 as a regulator of proliferative life-span and tumour progression.
Biol. Signals
5:139-153[Medline].
|
| 56.
|
Xu, L.,
J.-K. Yee,
J. Wolff, and T. Friedmann.
1989.
Factors affecting long-term stability of Moloney murine leukemia virus-based vectors.
Virology
171:331-341[Medline].
|
| 57.
|
Youngren, K.,
E. Jeanclos,
H. Aviv,
M. Kimura,
J. Stock,
M. Hanna,
J. Skurnick,
A. Bardeguez, and A. Aviv.
1998.
Synchrony in telomere length of the human fetus.
Hum. Genet.
102:640-643[Medline].
|
| 57a.
| Yu, L. Unpublished data.
|
| 58.
|
Zakian, V. A.
1989.
Structure and function of telomeres.
Annu. Rev. Genet.
23:579-604[Medline].
|
| 59.
|
Zhong, Z.,
L. Shiue,
S. Kaplan, and T. de Lange.
1992.
A mammalian factor that binds telomeric TTAGGG repeats in vitro.
Mol. Cell. Biol.
12:4834-4843[Abstract/Free Full Text].
|
Molecular and Cellular Biology, March 1999, p. 1864-1870, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Huang, X.-Q., Wang, J., Liu, J.-P., Feng, H., Liu, W.-B., Yan, Q., Liu, Y., Sun, S.-M., Deng, M., Gong, L., Liu, Y., Li, D. W.-C.
(2005). hTERT Extends Proliferative Lifespan and Prevents Oxidative Stress-Induced Apoptosis in Human Lens Epithelial Cells. IOVS
46: 2503-2513
[Abstract]
[Full Text]
-
Wang, S., Zhu, J.
(2004). The hTERT Gene Is Embedded in a Nuclease-resistant Chromatin Domain. J. Biol. Chem.
279: 55401-55410
[Abstract]
[Full Text]
-
Shahrabani-Gargir, L., Pandita, T. K., Werner, H.
(2004). Ataxia-Telangiectasia Mutated Gene Controls Insulin-Like Growth Factor I Receptor Gene Expression in a Deoxyribonucleic Acid Damage Response Pathway via Mechanisms Involving Zinc-Finger Transcription Factors Sp1 and WT1. Endocrinology
145: 5679-5687
[Abstract]
[Full Text]
-
Taylor, L. M., James, A., Schuller, C. E., Brce, J., Lock, R. B., MacKenzie, K. L.
(2004). Inactivation of p16INK4a, with Retention of pRB and p53/p21cip1 Function, in Human MRC5 Fibroblasts That Overcome a Telomere-independent Crisis during Immortalization. J. Biol. Chem.
279: 43634-43645
[Abstract]
[Full Text]
-
Ladetto, M., Compagno, M., Ricca, I., Pagano, M., Rocci, A., Astolfi, M., Drandi, D., di Celle, P. F., Dell'Aquila, M., Mantoan, B., Vallet, S., Pagliano, G., De Marco, F., Francese, R., Santo, L., Cuttica, A., Marinone, C., Boccadoro, M., Tarella, C.
(2004). Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood
103: 4644-4649
[Abstract]
[Full Text]
-
Sipila, P., Shariatmadari, R., Huhtaniemi, I. T., Poutanen, M.
(2004). Immortalization of Epididymal Epithelium in Transgenic Mice Expressing Simian Virus 40 T Antigen: Characterization of Cell Lines and Regulation of the Polyoma Enhancer Activator 3. Endocrinology
145: 437-446
[Abstract]
[Full Text]
-
Palanca-Wessels, M. C. A., Klingelhutz, A., Reid, B. J., Norwood, T. H., Opheim, K. E., Paulson, T. G., Feng, Z., Rabinovitch, P. S.
(2003). Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis
24: 1183-1190
[Abstract]
[Full Text]
-
Hahn, W. C.
(2003). Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer. JCO
21: 2034-2043
[Abstract]
[Full Text]
-
Hahn, W. C., Weinberg, R. A.
(2002). Rules for Making Human Tumor Cells. NEJM
347: 1593-1603
[Full Text]
-
Banik, S. S. R., Guo, C., Smith, A. C., Margolis, S. S., Richardson, D. A., Tirado, C. A., Counter, C. M.
(2002). C-Terminal Regions of the Human Telomerase Catalytic Subunit Essential for In Vivo Enzyme Activity. Mol. Cell. Biol.
22: 6234-6246
[Abstract]
[Full Text]
-
Martin, J. A., Forest, E., Block, J. A., Klingelhutz, A. J., Whited, B., Gitelis, S., Wilkey, A., Buckwalter, J. A.
(2002). Malignant Transformation in Human Chondrosarcoma Cells Supported by Telomerase Activation and Tumor Suppressor Inactivation. Cell Growth Differ.
13: 397-407
[Abstract]
[Full Text]
-
Demeterco, C., Itkin-Ansari, P., Tyrberg, B., Ford, L. P., Jarvis, R. A., Levine, F.
(2002). c-Myc Controls Proliferation Versus Differentiation in Human Pancreatic Endocrine Cells. J. Clin. Endocrinol. Metab.
87: 3475-3485
[Abstract]
[Full Text]
-
Marcotte, R., Wang, E.
(2002). Replicative Senescence Revisited. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
57: B257-269
[Abstract]
[Full Text]
-
Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., Weinberg, R. A.
(2002). Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation. Mol. Cell. Biol.
22: 2111-2123
[Abstract]
[Full Text]
-
Mergny, J.-L., Riou, J.-F., Mailliet, P., Teulade-Fichou, M.-P., Gilson, E.
(2002). Natural and pharmacological regulation of telomerase. Nucleic Acids Res
30: 839-865
[Abstract]
[Full Text]
-
Darimont, C., Avanti, O., Tromvoukis, Y., Vautravers-Leone, P., Kurihara, N., Roodman, G. D., Colgin, L. M., Tullberg-Reinert, H., Pfeifer, A. M. A., Offord, E. A., Mace, K.
(2002). SV40 T Antigen and Telomerase Are Required to Obtain Immortalized Human Adult Bone Cells without Loss of the Differentiated Phenotype. Cell Growth Differ.
13: 59-67
[Abstract]
[Full Text]
-
Goodwin, E. C., DiMaio, D.
(2001). Induced Senescence in HeLa Cervical Carcinoma Cells Containing Elevated Telomerase Activity and Extended Telomeres. Cell Growth Differ.
12: 525-534
[Abstract]
[Full Text]
-
Alexander, K., Hinds, P. W.
(2001). Requirement for p27KIP1 in Retinoblastoma Protein-Mediated Senescence. Mol. Cell. Biol.
21: 3616-3631
[Abstract]
[Full Text]
-
Shay, J. W., Zou, Y., Hiyama, E., Wright, W. E.
(2001). Telomerase and cancer. Hum Mol Genet
10: 677-685
[Abstract]
[Full Text]
-
Dufayet de la Tour, D., Halvorsen, T., Demeterco, C., Tyrberg, B., Itkin-Ansari, P., Loy, M., Yoo, S.-J., Hao, E., Bossie, S., Levine, F.
(2001). {beta}-Cell Differentiation from a Human Pancreatic Cell Line in Vitro and in Vivo. Mol. Endocrinol.
15: 476-483
[Abstract]
[Full Text]
-
Meyerson, M.
(2000). Role of Telomerase in Normal and Cancer Cells. JCO
18: 2626-2634
[Abstract]
[Full Text]
-
Ouellette, M. M., Liao, M., Herbert, B.-S., Johnson, M., Holt, S. E., Liss, H. S., Shay, J. W., Wright, W. E.
(2000). Subsenescent Telomere Lengths in Fibroblasts Immortalized by Limiting Amounts of Telomerase. J. Biol. Chem.
275: 10072-10076
[Abstract]
[Full Text]
-
Reddel, R. R.
(2000). The role of senescence and immortalization in carcinogenesis. Carcinogenesis
21: 477-484
[Abstract]
[Full Text]
-
LIU, J.-P.
(1999). Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J.
13: 2091-2104
[Abstract]
[Full Text]
-
Masutomi, K., Kaneko, S., Hayashi, N., Yamashita, T., Shirota, Y., Kobayashi, K., Murakami, S.
(2000). Telomerase Activity Reconstituted in Vitro with Purified Human Telomerase Reverse Transcriptase and Human Telomerase RNA Component. J. Biol. Chem.
275: 22568-22573
[Abstract]
[Full Text]